1. Home
  2. GKOS vs SSRM Comparison

GKOS vs SSRM Comparison

Compare GKOS & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • SSRM
  • Stock Information
  • Founded
  • GKOS 1998
  • SSRM 1946
  • Country
  • GKOS United States
  • SSRM United States
  • Employees
  • GKOS N/A
  • SSRM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • SSRM Precious Metals
  • Sector
  • GKOS Health Care
  • SSRM Industrials
  • Exchange
  • GKOS Nasdaq
  • SSRM Nasdaq
  • Market Cap
  • GKOS 5.4B
  • SSRM 4.6B
  • IPO Year
  • GKOS 2015
  • SSRM 1996
  • Fundamental
  • Price
  • GKOS $87.64
  • SSRM $23.73
  • Analyst Decision
  • GKOS Strong Buy
  • SSRM Hold
  • Analyst Count
  • GKOS 13
  • SSRM 4
  • Target Price
  • GKOS $120.38
  • SSRM $19.36
  • AVG Volume (30 Days)
  • GKOS 718.5K
  • SSRM 3.6M
  • Earning Date
  • GKOS 10-29-2025
  • SSRM 11-04-2025
  • Dividend Yield
  • GKOS N/A
  • SSRM N/A
  • EPS Growth
  • GKOS N/A
  • SSRM N/A
  • EPS
  • GKOS N/A
  • SSRM 0.80
  • Revenue
  • GKOS $432,953,000.00
  • SSRM $1,302,616,000.00
  • Revenue This Year
  • GKOS $28.90
  • SSRM $55.88
  • Revenue Next Year
  • GKOS $25.57
  • SSRM $17.65
  • P/E Ratio
  • GKOS N/A
  • SSRM $29.09
  • Revenue Growth
  • GKOS 26.70
  • SSRM 6.22
  • 52 Week Low
  • GKOS $77.10
  • SSRM $5.06
  • 52 Week High
  • GKOS $163.71
  • SSRM $25.98
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.74
  • SSRM 56.61
  • Support Level
  • GKOS $82.19
  • SSRM $21.86
  • Resistance Level
  • GKOS $86.74
  • SSRM $25.98
  • Average True Range (ATR)
  • GKOS 3.27
  • SSRM 1.16
  • MACD
  • GKOS 0.56
  • SSRM -0.14
  • Stochastic Oscillator
  • GKOS 82.87
  • SSRM 45.27

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: